SUZHOU, China, Feb. 23, 2026 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for ...

Froedtert surgeons used an FDA‑approved "glowing" drug to find a tiny lung tumor and spare healthy lung tissue.

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...

Introduction of a Differentiated Bispecific Nano ADC Positioned to Compete in Major Global Oncology Markets BOSTON, MA, ...

In response to the U.S. Environmental Protection Agency (EPA)’s release of the final rule today to roll back the updated limits on mercury and air toxics from power plants finalized in 2024, American ...

Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 2:30 PM ESTCompany ParticipantsRafael Amado - President and Head ...

Shira Kupperman Boehler, like an increasing number of women, didn't fit the profile for the typical lung cancer patient. Now, she's spreading awareness.

Eli Lilly (LLY) stock is in focus as the company posts late-stage trial win for Retevmo (selpercatinib) lung cancer therapy as adjuvant therapy. Read more here.

Lung cancer in never smokers is an increasingly recognized global health issue with distinct biological drivers, environmental risk factors, and genetic susceptibilities. Improved risk modelling, ...

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...

FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...

Rebecca Siegel, MPH, reveals key insights on lung cancer trends, survival rates, and the need for targeted interventions in diverse populations. In part 1 of an interview with Targeted Oncology, ...